Intellectus Partners LLC Has $1.77 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Intellectus Partners LLC trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,235 shares of the medical equipment provider’s stock after selling 275 shares during the period. Intellectus Partners LLC’s holdings in Intuitive Surgical were worth $1,766,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in ISRG. Valeo Financial Advisors LLC increased its stake in Intuitive Surgical by 19.4% in the 3rd quarter. Valeo Financial Advisors LLC now owns 3,492 shares of the medical equipment provider’s stock valued at $1,021,000 after buying an additional 567 shares during the last quarter. Arthur M. Cohen & Associates LLC increased its stake in Intuitive Surgical by 0.6% in the 3rd quarter. Arthur M. Cohen & Associates LLC now owns 8,816 shares of the medical equipment provider’s stock valued at $2,577,000 after buying an additional 54 shares during the last quarter. Golden State Equity Partners increased its stake in Intuitive Surgical by 98.9% in the 3rd quarter. Golden State Equity Partners now owns 1,215 shares of the medical equipment provider’s stock valued at $355,000 after buying an additional 604 shares during the last quarter. Avestar Capital LLC grew its position in shares of Intuitive Surgical by 3.9% in the 3rd quarter. Avestar Capital LLC now owns 3,033 shares of the medical equipment provider’s stock valued at $887,000 after acquiring an additional 113 shares during the period. Finally, Lake Street Financial LLC grew its position in shares of Intuitive Surgical by 5.3% in the 3rd quarter. Lake Street Financial LLC now owns 990 shares of the medical equipment provider’s stock valued at $293,000 after acquiring an additional 50 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a research report on Friday, January 19th. Truist Financial lifted their price objective on shares of Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a research report on Wednesday, January 24th. Robert W. Baird decreased their price objective on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating for the company in a research report on Friday, April 19th. BTIG Research lifted their price objective on shares of Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a research report on Friday, April 19th. Finally, StockNews.com downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Five investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $396.17.

Insider Buying and Selling at Intuitive Surgical

In other news, VP Marshall Mohr sold 108,790 shares of the business’s stock in a transaction that occurred on Wednesday, February 28th. The shares were sold at an average price of $385.08, for a total value of $41,892,853.20. Following the completion of the transaction, the vice president now directly owns 26,877 shares in the company, valued at approximately $10,349,795.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, VP Marshall Mohr sold 108,790 shares of the business’s stock in a transaction that occurred on Wednesday, February 28th. The shares were sold at an average price of $385.08, for a total value of $41,892,853.20. Following the completion of the transaction, the vice president now directly owns 26,877 shares in the company, valued at approximately $10,349,795.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total transaction of $741,400.00. Following the completion of the transaction, the director now owns 25,319 shares of the company’s stock, valued at $9,385,753.30. The disclosure for this sale can be found here. Insiders sold 249,418 shares of company stock valued at $96,300,959 in the last quarter. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Up 0.6 %

NASDAQ ISRG traded up $2.21 during trading on Friday, reaching $375.33. The company’s stock had a trading volume of 927,845 shares, compared to its average volume of 1,564,565. The firm has a market capitalization of $133.13 billion, a price-to-earnings ratio of 67.75, a price-to-earnings-growth ratio of 4.85 and a beta of 1.36. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $403.76. The firm has a 50 day moving average price of $386.19 and a 200 day moving average price of $346.29.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. The firm had revenue of $1.89 billion during the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The business’s revenue for the quarter was up 11.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.00 EPS. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.